CAS 201853-92-1

Meosuc-Ala-Phe-Lys-Amc Tfa

Description:

Meosuc-Ala-Phe-Lys-Amc Tfa, identified by the CAS number 201853-92-1, is a synthetic peptide that serves as a substrate for various biochemical assays, particularly in the study of proteolytic enzymes. This compound is characterized by its specific amino acid sequence, which includes methionine sulfoxide (Meosuc), alanine (Ala), phenylalanine (Phe), lysine (Lys), and an amide group (Amc) that enhances its fluorescent properties. The presence of trifluoroacetic acid (Tfa) indicates that it is likely in a salt form, which is commonly used to stabilize peptides during synthesis and purification processes. The peptide's structure allows it to interact with enzymes, making it valuable in research related to enzyme kinetics and inhibition studies. Additionally, its fluorescent properties enable real-time monitoring of enzymatic reactions, providing insights into enzyme activity and function. Overall, Meosuc-Ala-Phe-Lys-Amc Tfa is a versatile tool in biochemical research, particularly in the fields of enzymology and molecular biology.

MeOSuc-Ala-Phe-Lys-AMC

CAS: 201853-92-1

MeOSuc-AFK-AMC, a highly sensitive fluorogenic substrate for plasmin.

Formula: C₃₃H₄₁N₅O₈

Purity: 95.1%

Color and Shape: White Lyophilisate

Molecular weight: 635.72

Ref: 01-4006754

L-Lysinamide, N-(4-methoxy-1,4-dioxobutyl)-L-alanyl-L-phenylalanyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-, mono(trifluoroacetate) (9CI)

CAS: 201853-92-1

Formula: C₃₅H₄₂F₃N₅O₁₀

Molecular weight: 749.7307

Ref: IN-DA0027VH

MeOSuc-Ala-Phe-Lys-AMC trifluoroacetate salt

CAS: 201853-92-1

MeOSuc-Ala-Phe-Lys-AMC is a compound that has a destabilizing effect on the vascular wall, due to its ability to inhibit proteolytic activity. It is also able to reduce the level of angiogenic factors, and thus has an anti-angiogenic effect. MeOSuc-Ala-Phe-Lys-AMC has been shown to have a macroscopic effect on vessels in tissue culture, and this can be observed through leucocyte migration. MeOSuc-Ala-Phe-Lys-AMC has also been shown to cause haemorrhagic changes in microvessels and muscle cells. This compound is also able to inhibit placental growth factor and muscle cell proliferation, as well as reducing the number of microvessels in the placenta.

Formula: C₃₃H₄₁N₅O₈•C₂HF₃O₂

Purity: Min. 95 Area-%

Color and Shape: Powder

Molecular weight: 749.73 g/mol

Ref: 3D-FM110512